Long-term results of autologous marrow transplantation for relapsed or refractory male or female germ cell tumors

被引:21
作者
Mandanas, RA [1 ]
Saez, RA [1 ]
Epstein, RB [1 ]
Confer, DL [1 ]
Selby, GB [1 ]
机构
[1] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Hematol Oncol Sect,Blood & Marrow Transplantat Pr, Oklahoma City, OK USA
关键词
germ cell tumors; bone marrow transplantation; relapsed; cisplatin-refractory;
D O I
10.1038/sj.bmt.1701132
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Twenty-one patients with relapsed or refractory germ cell tumors were treated with high-dose chemotherapy and marrow transplantation (HDC/BMT) from 1982-1993, Primary sites of disease were testis (17), ovary (three), and pineal gland (one), Pathology included dysgerminoma (one), choriocarcinoma with adenocarcinoma (one), seminoma (four), and nonseminoma or mixed germ cell tumor (15), Nineteen had at least two prior chemotherapy regimens and eight had cisplatin-refractory disease defined as progression within 4 weeks of a cycle of cisplatin-based chemotherapy. HDC regimens were mostly combinations of cyclophosphamide with etoposide and cisplatin or carboplatin, There were only two treatment-related deaths (aspergillosis and interstitial pneumonitis), Times to engraftment of granulocytes (21 +/- 8.3 days) and platelets (32 +/- 20.2 days) were reasonable with only the last nine patients receiving growth factors, At a minimum of 4 years follow-up, eight patients have died of disease, six of whom were cisplatin-refractory prior to transplant, Eleven patients (52% overall) are alive and continuously free of disease after 4-10 years including one of three with refractory ovarian germ cell tumor, HDC/BMT provides significant long-term disease-free survival as salvage therapy for both male and female relapsed germ cell tumor patients who are not refractory to cisplatin.
引用
收藏
页码:569 / 576
页数:8
相关论文
共 30 条
  • [1] HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH POOR-PROGNOSIS NONSEMINOMATOUS GERM-CELL TUMORS
    BARNETT, MJ
    COPPIN, CML
    MURRAY, N
    NEVILL, TJ
    REECE, DE
    KLINGEMANN, HG
    SHEPHERD, JD
    NANTEL, SH
    SUTHERLAND, HJ
    PHILLIPS, GL
    [J]. BRITISH JOURNAL OF CANCER, 1993, 68 (03) : 594 - 598
  • [2] High-dose chemotherapy as salvage treatment in germ cell tumors: A Multivariate analysis of prognostic variables
    Beyer, J
    Kramar, A
    Mandanas, R
    Linkesch, W
    Greinix, A
    Droz, JP
    Pico, JL
    Diehl, A
    Bokemeyer, C
    Schmoll, HJ
    Nichols, CR
    Einhorn, LH
    Siegert, W
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) : 2638 - 2645
  • [3] PROGNOSTIC FACTORS FOR FAVORABLE OUTCOME IN DISSEMINATED GERM-CELL TUMORS
    BIRCH, R
    WILLIAMS, S
    CONE, A
    EINHORN, L
    ROARK, P
    TURNER, S
    GRECO, FA
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (03) : 400 - 407
  • [4] BROUN ER, 1995, BONE MARROW TRANSPL, V16, P353
  • [5] BROUN ER, 1994, CANCER, V73, P1716, DOI 10.1002/1097-0142(19940315)73:6<1716::AID-CNCR2820730627>3.0.CO
  • [6] 2-L
  • [7] BROUN ER, 1991, CANCER, V68, P1513, DOI 10.1002/1097-0142(19911001)68:7<1513::AID-CNCR2820680708>3.0.CO
  • [8] 2-8
  • [9] LONG-TERM OUTCOME OF PATIENTS WITH RELAPSED AND REFRACTORY GERM-CELL TUMORS TREATED WITH HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW RESCUE
    BROUN, ER
    NICHOLS, CR
    KNEEBONE, P
    WILLIAMS, SD
    LOEHRER, PJ
    EINHORN, LH
    TRICOT, GJK
    [J]. ANNALS OF INTERNAL MEDICINE, 1992, 117 (02) : 124 - 128
  • [10] BROUN ER, 1991, BONE MARROW TRANSPL, V7, P53